Jpmorgan Chase & CO Exagen Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding XGN
# of Institutions
39Shares Held
6.3MCall Options Held
2.5KPut Options Held
200-
Rtw Investments, LP New York, NY1.51MShares$3.73 Million0.05% of portfolio
-
Cowen And Company, LLC891KShares$2.2 Million0.04% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT762KShares$1.88 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY545KShares$1.35 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$1.21 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $40.2M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...